These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8152238

  • 1. Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography.
    Miyazawa H, Osmont A, Petit-Taboué MC, Tillet I, Travère JM, Young AR, Barré L, MacKenzie ET, Baron JC.
    J Neurosci Methods; 1993 Dec; 50(3):263-72. PubMed ID: 8152238
    [Abstract] [Full Text] [Related]

  • 2. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD, Pawlik G, Herholz K, Wagner R, Göldner H, Wienhard K.
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [Abstract] [Full Text] [Related]

  • 3. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
    Kuwabara H, Gjedde A.
    J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
    [Abstract] [Full Text] [Related]

  • 4. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K, Lucignani G, Moresco RM, Rizzo G, Gilardi MC, Messa C, Colombo F, Fazio F, Sokoloff L.
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [Abstract] [Full Text] [Related]

  • 5. In vivo measurement of [18F]fluorodeoxyglucose rate constants in rat brain by external coincidence counting.
    Redies C, Matsuda H, Diksic M, Meyer E, Yamamoto YL.
    Neuroscience; 1987 Aug; 22(2):593-9. PubMed ID: 3670599
    [Abstract] [Full Text] [Related]

  • 6. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
    Evans AC, Diksic M, Yamamoto YL, Kato A, Dagher A, Redies C, Hakim A.
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
    [Abstract] [Full Text] [Related]

  • 7. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
    Kuwabara H, Evans AC, Gjedde A.
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
    [Abstract] [Full Text] [Related]

  • 8. Analysis of kinetic rate constants in [18F]fluorodeoxyglucose model using a least square fitting package SALS (statistical analysis with least squares).
    Uehara S, Kuwabara Y, Ichiya Y, Otsuka M, Ayabe Y, Miyake Y, Masuda K, Yoshimura A.
    Radioisotopes; 1987 Dec; 36(12):653-6. PubMed ID: 3502293
    [Abstract] [Full Text] [Related]

  • 9. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.
    Dhawan V, Moeller JR, Strother SC, Evans AC, Rottenberg DA.
    J Nucl Med; 1989 Sep; 30(9):1483-8. PubMed ID: 2788721
    [Abstract] [Full Text] [Related]

  • 10. [Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].
    Enomoto K, Fukunaga T, Okazumi S, Asano T, Kikuchi T, Yamamoto H, Nagashima T, Isono K, Itoh H, Imazeki K.
    Kaku Igaku; 1991 Nov; 28(11):1353-6. PubMed ID: 1663176
    [Abstract] [Full Text] [Related]

  • 11. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE.
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [Abstract] [Full Text] [Related]

  • 12. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
    Piert M, Koeppe RA, Giordani B, Minoshima S, Kuhl DE.
    J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver.
    Choi Y, Hawkins RA, Huang SC, Brunken RC, Hoh CK, Messa C, Nitzsche EU, Phelps ME, Schelbert HR.
    J Nucl Med; 1994 May; 35(5):818-23. PubMed ID: 8176464
    [Abstract] [Full Text] [Related]

  • 14. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
    Herholz K, Rudolf J, Heiss WD.
    J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
    [Abstract] [Full Text] [Related]

  • 15. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling.
    Sugawara Y, Zasadny KR, Grossman HB, Francis IR, Clarke MF, Wahl RL.
    Radiology; 1999 Apr; 211(1):249-56. PubMed ID: 10189480
    [Abstract] [Full Text] [Related]

  • 16. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K, Pawlik G, Nebeling B, Rudolf J, Fink G, Hamacher K, Stöcklin G, Heiss WD.
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.
    Okazumi S, Isono K, Enomoto K, Kikuchi T, Ozaki M, Yamamoto H, Hayashi H, Asano T, Ryu M.
    J Nucl Med; 1992 Mar; 33(3):333-9. PubMed ID: 1311035
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Short dynamic FDG-PET imaging protocol for patients with lung cancer.
    Torizuka T, Nobezawa S, Momiki S, Kasamatsu N, Kanno T, Yoshikawa E, Futatsubashi M, Okada H, Ouchi Y.
    Eur J Nucl Med; 2000 Oct; 27(10):1538-42. PubMed ID: 11083544
    [Abstract] [Full Text] [Related]

  • 20. 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
    Spence AM, Muzi M, Mankoff DA, O'Sullivan SF, Link JM, Lewellen TK, Lewellen B, Pham P, Minoshima S, Swanson K, Krohn KA.
    J Nucl Med; 2004 Oct; 45(10):1653-9. PubMed ID: 15471829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.